Ongoing Exposure of UK Infants to Vaccine Serotype Pneumococci

Loading...
Thumbnail Image
File version

Accepted Manuscript (AM)

Author(s)
Slack, Mary
Vyse, Andrew
Madhava, Harish
Reinert, Ralf-Rene
Ellsbury, Gillian
Czudek, Carole
Gessner, Bradford
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2019
Size
File type(s)
Location
License
Abstract

To the Editors: We read with interest the article by Makwana et al.1 The authors note that most childhood invasive pneumococcal disease (IPD) cases are now due to non-13 valent pneumococcal conjugate vaccine (PCV13) serotypes though PCV13 serotypes remain in circulation with serotypes 3 and 19A listed among the top 10 that caused IPD in children in 2015/16. Of the 25 cases with PCV13-type IPD in 2015/16, 11 (44%) were due to serotype 19A.

Journal Title

Pediatric Infectious Disease Journal

Conference Title
Book Title
Edition
Volume

38

Issue

4

Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement

© 2019 Lippincott Williams & Wilkins. This is a non-final version of an article published in final form in the Pediatric Infectious Disease Journal, Volume 38 - Issue 4 - p 444. Reproduced in accordance with the copyright policy of the publisher. Please refer to the journal link for access to the definitive, published version.

Item Access Status
Note
Access the data
Related item(s)
Subject

Paediatrics and Reproductive Medicine

Public Health and Health Services

Science & Technology

Life Sciences & Biomedicine

Immunology

Infectious Diseases

Persistent link to this record
Citation

Slack, M; Vyse, A; Madhava, H; Reinert, R-R; Ellsbury, G; Czudek, C; Gessner, B, Ongoing Exposure of UK Infants to Vaccine Serotype Pneumococci, Pediatric Infectious Disease Journal, 2019, 38 (4), pp. 444-444

Collections